Semaglutide injections, also known as Ozempic and Wegovy, were originally approved only for treating diabetic patients
Compounded prescription medications are generally evaluated under separate state and federal pharmacy regulations rather than Proposition 65's consumer product framework
To strengthen your claim, be prepared to provide: Prescription records showing use of Ozempic, Wegovy, or Mounjaro Medical records indicating diagnosis and treatment of GI issues Doctors notes on symptom progression Emergency room visit records Test results, including gastric emptying studies Out-of-pocket costs and lost income documentation A personal journal detailing how the condition has impacted your daily life Morgan & Morgan can help gather this information and present it effectively
Typical Dose 1-2 mg (injection) or topical application Frequency Daily (topical) or 2-3 times weekly (injection) Duration 8-12 weeks Administration Subcutaneous injection or topical cream/serum Often used topically in skincare products
For detailed storage timelines by peptide type, see how long reconstituted peptides last in the fridge and at room temperature
Earlier investigations within the STEP initiative were confined to durations not exceeding 68 weeks
